Purpose: This work aims to demystify Knowledge Graphs (KGs) in pharmacovigilance (PV). It complements the scoping review within this issue. By bridging knowledge gaps and stimulating interest, further engagement with this topic by pharmacovigilance professionals will be facilitated.
Methods: We elucidate fundamental KGs concepts and terminology, followed by delineating a sequence of implementation steps: use case definition, data type selection, data sourcing, KG construction, KG embedding, and deriving actionable insights. Information technology options and limitations are also explored.
Findings: KGs in pharmacovigilance is a multi-disciplinary field involving information technology, machine learning, biology, and PV. We were able to synthesize the relevant core concepts to create an intuitive exposition of KGs in PV.
Implications: This work demystifies KGs with a pharmacovigilance focus, preparing readers for the accompanying in-depth scoping review. that follows. It lays the groundwork for advancing PV research and practice by emphasizing the importance of engaging with vigilance experts. This approach enhances knowledge sharing and collaboration, contributing to more effective and informed pharmacovigilance efforts and optimal assessment and deployment of KGs in PV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clinthera.2024.03.006 | DOI Listing |
Clin Ther
July 2024
Department of Statistics, Rutgers University, Piscataway, New Jersey. Electronic address:
Purpose: This work aims to demystify Knowledge Graphs (KGs) in pharmacovigilance (PV). It complements the scoping review within this issue. By bridging knowledge gaps and stimulating interest, further engagement with this topic by pharmacovigilance professionals will be facilitated.
View Article and Find Full Text PDFCirculation
March 2023
Department of Cardiology (M.C.H.L., D.M., K.G.S., N.D.J., M.P., M.S., G.G., T.B.-S.), Copenhagen University Hospital-Herlev & Gentofte, Denmark.
JMIR Med Inform
October 2021
Department of Information Systems and Analytics, National University of Singapore, Singapore, Singapore.
Background: Adverse drug events (ADEs) are unintended side effects of drugs that cause substantial clinical and economic burdens globally. Not all ADEs are discovered during clinical trials; therefore, postmarketing surveillance, called pharmacovigilance, is routinely conducted to find unknown ADEs. A wealth of information, which facilitates ADE discovery, lies in the growing body of biomedical literature.
View Article and Find Full Text PDFDrug Saf
November 2021
Institute of Applied Biosciences, Centre for Research and Technology Hellas, 6th Km. Charilaou, Thermi Road, PO Box 60361, 57001, Thermi, Thessaloniki, Greece.
Introduction: Information technology (IT) plays an important role in the healthcare landscape via the increasing digitization of medical data and the use of modern computational paradigms such as machine learning (ML) and knowledge graphs (KGs). These 'intelligent' technical paradigms provide a new digital 'toolkit' supporting drug safety and healthcare processes, including 'active pharmacovigilance'. While these technical paradigms are promising, intelligent systems (ISs) are not yet widely adopted by pharmacovigilance (PV) stakeholders, namely the pharma industry, academia/research community, drug safety monitoring organizations, regulatory authorities, and healthcare institutions.
View Article and Find Full Text PDFVaccine
December 2017
ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!